Role of genetic polymorphisms and ovarian cancer susceptibility.

@article{Fasching2009RoleOG,
  title={Role of genetic polymorphisms and ovarian cancer susceptibility.},
  author={Peter A. Fasching and Simon A. Gayther and Leigh J. Pearce and Joellen M Schildkraut and Ellen L. Goode and Falk Clemens Thiel and Georgia Chenevix-Trench and Jenny Chang-Claude and Shan Wang-gohrke and Susan J Ramus and Paul D. Pharoah and Andrew Berchuck},
  journal={Molecular oncology},
  year={2009},
  volume={3 2},
  pages={
          171-81
        }
}
The value of identifying women with an inherited predisposition to epithelial ovarian cancer has become readily apparent with the identification of the BRCA1, and BRCA2 genes. Women who inherit a deleterious mutation in either of these genes have a very high lifetime risk of ovarian cancer (10-60%) and to some extent, increased risks of fallopian tube and peritoneal cancer. These highly lethal cancers are almost completely prevented by prophylactic salpingoophorectomy. BRCA1/2 mutation testing… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

The new face of ovarian cancer modeling: better prospects for detection and treatment

  • F1000 medicine reports
  • 2011
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.

  • Journal of the Formosan Medical Association = Taiwan yi zhi
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND